Skip to content

Author

Pudong Qian

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Optimal Sequencing of First-Line Immune Checkpoint Inhibitors With Definitive Chemoradiotherapy: A Multicenter Real-World Cohort Study Comparing Induction, Concurrent, and Consolidation Strategies for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma.

While first-line immune checkpoint inhibitors (ICIs) combined with chemoradiotherapy (CRT) represent a crucial advancement for unresectable locally advanced esophageal squamous cell carcinoma (ESCC), the optimal sequencing of these modalities remains unresolved. To evaluate the efficacy and safety of induction, concurr...

Xiao-Han Zhao, Shi-Wang Wen, Chun-Yang Song et al. · 0 citations
Open access Aug 2026

A real-world multicenter study on postoperative adjuvant treatment patterns and prognostic implications following neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma

For ESCC patients receiving nICT, postoperative adjuvant treatment can provide survival benefits, particularly more pronounced in non-pCR patients and those with advanced postoperative pathological stages, particularly more pronounced in non-pCR patients and those with advanced postoperative pathological stages.

Xue-Yuan Zhang, Hong-Mei Gao, J. Cao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.